Loss of bone density with inhaled triamcinolone in Lung Health Study II. (Q45063936)

9 December 2017

title

Loss of bone density with inhaled triamcinolone in Lung Health Study II. (English)

1 reference

9 December 2017

3

1 reference

9 December 2017

Paul D Scanlon

1

1 reference

9 December 2017

John E Connett

2

1 reference

9 December 2017

Donald P Tashkin

4

1 reference

9 December 2017

Thelma Madhok

5

1 reference

9 December 2017

Melissa Skeans

6

1 reference

9 December 2017

Paul C Carpenter

7

1 reference

9 December 2017

William C Bailey

8

1 reference

9 December 2017

A Sonia Buist

9

1 reference

9 December 2017

Michael Eichenhorn

10

1 reference

9 December 2017

Richard E Kanner

11

1 reference

9 December 2017

Gail Weinmann

12

1 reference

9 December 2017

Lung Health Study Research Group

13

1 reference

9 December 2017

language of work or name

English

0 references

publication date

16 September 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

9 December 2017

published in

1 reference

9 December 2017

volume

170

1 reference

9 December 2017

issue

12

1 reference

9 December 2017

page(s)

1302-1309

1 reference

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Adverse effects of corticosteroid therapy for COPD. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Effects of inhaled glucocorticoids on bone density in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Inhaled corticosteroids and hip fracture: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

21 January 2018

COPD and osteoporosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

A critical review of bone mass and the risk of fractures in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Differential effects of endocrine dysfunction on the axial and the appendicular skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Lateral bone density measurements in osteoarthritis of the lumbar spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: a literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Inhaled corticosteroids, bone density, and risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1349OC

10.1164/RCCM.200310-1349OC

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference